Carregant...
Insilico drug repurposing using FDA approved drugs against Membrane protein of SARS-CoV-2
The novel coronavirus (SARS-CoV-2) outbreak has started taking away the millions of lives worldwide. Identification of known and approved drugs against novel coronavirus disease (COVID-19) seems to be an urgent need for the repurposing of the existing drugs. So, here we examined a safe strategy of u...
Guardat en:
| Publicat a: | J Pharm Sci |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Pharmacists Association®. Published by Elsevier Inc.
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7934671/ https://ncbi.nlm.nih.gov/pubmed/33684397 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.xphs.2021.03.004 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|